Drawing for MT2 MEDICAL

USPTO serial 86413639

MT2 MEDICAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUONGIORNO, CHRISTOPHER L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MT2 MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charlene A. Azema

CHARLENE A. AZEMA KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN ST FL 14IRVINE, CA 92614-8214UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Neurovascular medical devices and apparatus for treating neurovascular disease; minimally invasive neurovascular devices for the treatment of neurovascular and neurological conditions; neurovascular medical devices and apparatus, namely, medical devices to treat intravascular sites; neurovascular medical devices and apparatus for use in endovascular, cardiovascular, and neurovascular procedures; neurovascular medical devices and apparatus, namely, catheters and parts and fittings therefor, guidewires and parts and fittings therefor, neurovascular flow diverters, balloons, and stents; neurovascular medical devices and apparatus, namely, intra vascular and intra saccular flow diverters; neurovascular blood clot devices, namely, retrievable stents and manipulators; neurovascular embolization devices, namely, coils, plugs, embolic microspheres for embolization in the form of particles, and beads for use in the treatment of aneurysms, vascular occlusions, and for performing vascular embolizations; neurovascular devices for the treatment of vascular occlusions; neurovascular devices for performing vascular embolizations; neurovascular medical devices to treat intravascular sites, namely, intravascular implants comprised of artificial material; neurovascular embolization devices in the nature of an intravenous device in gel or liquid form which aid in the artificial development of an embolus used for performing vascular embolizations and for use in the treatment of aneurysms and vascular occlusionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 12, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 12, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2017EX3GSOU EXTENSION 3 GRANTED—
Aug 4, 2017EXT3SOU EXTENSION 3 FILED—
Aug 4, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2017EX2GSOU EXTENSION 2 GRANTED—
Feb 7, 2017EXT2SOU EXTENSION 2 FILED—
Feb 7, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 6, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2016EX1GSOU EXTENSION 1 GRANTED—
Aug 4, 2016EXT1SOU EXTENSION 1 FILED—
Aug 4, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 3, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 9, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 15, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 15, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 25, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 12, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 4, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 4, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Nov 4, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 4, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 4, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 19, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 19, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 6, 2015ALIEASSIGNED TO LIE—
Jul 24, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2015DOCKASSIGNED TO EXAMINER—
Oct 10, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Oct 9, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance